Healthcare Sector (XLV)
Defensive with growth subsector; policy-risk gated.
Health Care Select Sector SPDR (XLV) · Profile updated 2026-05-03
Macro Context
Healthcare occupies an unusual spot in the sector map: it's defensive enough to outperform during growth scares (pharma and managed care earnings are relatively recession-resilient) but contains genuine growth exposure through biotech and medical devices. The sector's 12% S&P 500 weight includes three distinct businesses, each with different macro sensitivities.
Large-cap pharma (LLY, JNJ, MRK, ABBV, PFE) is driven by patent cliffs, pipeline read-outs, and drug-pricing policy. The GLP-1 trade (LLY, NVO) has been the dominant sector alpha since 2023, adding hundreds of billions in market cap on obesity and diabetes demand. Managed care (UNH, ELV, CI) is policy-gated: Medicare Advantage rate notices, MLR ratios, and Medicaid redetermination cycles move prices.
Biotech (IBB, XBI) is the most rate-sensitive subsector. Small-cap biotech correlates with long-duration multiples the way small-cap growth does, and XBI typically tracks ARKK within 20 percentage points over rolling 12-month windows. When real yields fall, biotech re-rates aggressively; when they rise, biotech lags every defensive.
The policy risk tail is significant. Drug pricing (IRA negotiation, proposed caps), FDA approval timelines, and election-cycle rhetoric all drive sentiment-level moves. Convex tracks XLV alongside biotech ETFs (IBB), the 10-year real yield, and the XLV/XLY ratio (defensive tilt).
Primary Drivers
- ›GLP-1 franchise earnings (LLY, NVO)
- ›Drug pricing policy and Medicare negotiation lists
- ›FDA advisory committee outcomes
- ›Managed care rate notices and MLR trends
- ›Biotech / real-yield sensitivity
Convex Watch Signals
- ›XLV/SPY ratio (defensive tilt)
- ›IBB/XBI relative strength (biotech risk appetite)
- ›Large-cap pharma earnings-guidance revisions
- ›Medicare Advantage rate-notice cycles
- ›XLV/XLY ratio for defensive rotation
Regime Behavior
- Goldilocks
- Modestly supportive. Growth subsector benefits from falling discount rates.
- Reflation
- Mixed. Defensive tilt lags early, biotech reacts to rates.
- Stagflation
- Leads defensives. Demand is inelastic plus cost pass-through.
- Deflation
- Leads. Defensive earnings plus falling rates.
Live Related Indicators
Related Glossary
Frequently Asked Questions
What drives the Healthcare sector?+
Healthcare (XLV) is primarily driven by glp-1 franchise earnings (lly, nvo), drug pricing policy and medicare negotiation lists, fda advisory committee outcomes. These are the factors that move the ETF on both a cyclical and structural basis and where Convex focuses sector-specific data ingestion.
Which macro regime favors Healthcare?+
Healthcare typically leads in a Stagflation regime. Detailed regime behavior: Goldilocks, Modestly supportive. Growth subsector benefits from falling discount rates. Reflation, Mixed. Defensive tilt lags early, biotech reacts to rates. Stagflation, Leads defensives. Demand is inelastic plus cost pass-through. Deflation, Leads. Defensive earnings plus falling rates.
Which signals should I watch for Healthcare?+
Convex tracks the following for Healthcare: XLV/SPY ratio (defensive tilt); IBB/XBI relative strength (biotech risk appetite); Large-cap pharma earnings-guidance revisions; Medicare Advantage rate-notice cycles; XLV/XLY ratio for defensive rotation. These surface the earliest evidence of sector rotation or regime change.
What is the XLV ETF?+
Health Care Select Sector SPDR (XLV) provides equity exposure to the US healthcare sector. Healthcare currently represents roughly 12% of the S&P 500. The ETF is the primary vehicle Convex uses to track sector performance and relative strength versus the broader index.
How does Healthcare compare to the S&P 500?+
Over the past 90 days, XLV has underperformed the S&P 500 by 10.34 percentage points. Convex tracks the XLV/SPY ratio continuously as a leadership barometer; the current reading is discussed in the regime notes.
Get the daily macro editorial including sector rotation signals and regime change alerts in your inbox.
Related Sectors
Sector profile compiled from Convex macro research and live ETF data. Weightings approximate current S&P 500 composition and shift with market capitalization. For informational purposes only, not financial advice.